| Financial Year |
March 31 2021 |
| Monetary Funds |
31,025,000,000.00 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
92,000,000.00 |
| Accounts Receivable |
30,955,000,000.00 |
| Advances to Suppliers |
9,964,000,000.00 |
| Other Receivables |
4,106,000,000.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
4,655,000,000.00 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
2,478,000,000.00 |
| Other Current Assets |
8,669,000,000.00 |
| Total Current Assets |
92,756,000,000.00 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,438,000,000.00 |
| Long-term Equity Investment |
40,714,000,000.00 |
| Investment Properties |
225,000,000.00 |
| Fixed Assetes |
404,689,000,000.00 |
| Under-construction Projects |
53,509,000,000.00 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
38,033,000,000.00 |
| R&D expenses |
1,199,000,000.00 |
| Goodwill |
29,927,000,000.00 |
| Long-Term Deferred and Prepaid Expenses |
2,170,000,000.00 |
| Deferred Income Tax Assets |
8,519,000,000.00 |
| Other Non-Current Assets |
1,450,000,000.00 |
| Sub-Total of Non-Current Assets |
620,972,000,000.00 |
| Total Assets |
713,728,000,000.00 |
| Short-Term Loans |
12,992,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
12,491,000,000.00 |
| Accounts Payable |
97,659,000,000.00 |
| Accounts Received In Advance |
214,000,000.00 |
| Employee Compensation Payable |
12,953,000,000.00 |
| Taxes Payable |
2,534,000,000.00 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,846,000,000.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
18,699,000,000.00 |
| Other Current Liabilities |
7,338,000,000.00 |
| Sub-Total of Current Liabilities |
262,814,000,000.00 |
| Long-term Loans |
16,808,000,000.00 |
| Bonds Payable |
2,000,000,000.00 |
| Long-Term Accounts Payable |
135,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
67,000,000.00 |
| Deferred Income Tax Liabilities |
25,662,000,000.00 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
78,287,000,000.00 |
| Total Liabilities |
341,101,000,000.00 |
| Paid-In Capital(Or Share Stock) |
80,932,000,000.00 |
| Capital Surplus |
30,226,000,000.00 |
| Surplus Reserve |
79,854,000,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
179,425,000,000.00 |
| Minority Stockholder's Interest |
2,782,000,000.00 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
369,845,000,000.00 |
| Owner's Equity（Stockholder's Equity） |
372,627,000,000.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
713,728,000,000.00 |
